Herantis Pharma Plc’s financial reporting in 2015
Herantis Pharma Plc's financial reporting in 2015
Herantis Pharma Plc.
Company release 18 December 2014 at 10:00 am
Herantis Pharma will publish the following financial reports in 2015:
Financial Statements bulletin in regard to 2014 on Friday the 27th of February 2015
Interim Report on January-June 2015 on Wednesday the 19th of August 2015
The Annual General Meeting is planned to be held on Thursday the 9th of April 2015. The Board of Directors will present a formal notice of the AGM at a later stage.
Annual Report for 2014 will be published during the week 13/2015 in electronic format on the company's web site.
Herantis Pharma Plc., Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Capital Oy, telephone: +358 9 2538 0225
About Herantis Pharma Plc.
Herantis Pharma Plc. is a pharmaceutical company specialised in new drug research and development. The company focuses on diseases with an unmet clinical need. These diseases include for example dry eye syndrome, Parkinson's disease, and secondary lymphedema. We believe our drugs are the first or best in their class and have the potential to change treatment strategies of diseases. The shares of Herantis Pharma Plc. are listed on the First North Finland marketplace run by NASDAQ Helsinki stock exchange.